Supporting AI driven drug design
Combining Federated AI technology, quantum chemistry and drug design capabilities, Quibigen has a mission to create the largest global federated proprietary dataset and computational toolbox for AI driven drug design.
Qubigen's Federated AI draws insights from medical and pharmaceutical data without moving or seeing the data, allowing diversity through collaboration, to ensure unbiased and generalisable AI.
The company is focused on making drug discovery faster, cheaper, more efficient and more collaborative. By training Generative AI and using molecular mechanics and quantum chemistry, modelled on real-world experimental results, Qubigen may be able to discover new medicines that no one single institute could discover on their own.
“The reason for connecting to GigCity is that we are a technology company in a data-hungry industry. Typically, data needed to train real-world AI that works and scales well is large, or requires continual access to cloud services."
"Our company needs to make use of the best internet connectivity to deliver AI solutions to our collaborators and clients"
Through connection to GigCity, Qubigen appreciates the access to fast upload and download speeds when needing to access large amounts of testing data. Dr Hall says, “In addition, we require continual and uninterrupted internet connectivity, so using GigCity just made sense.”
Dr Hall’s vision is for Qubigen to become a key collaborative enabler for drug discovery worldwide.
“We see we could be placed to bring together partners from around the world, large institutes across the US as well as Australia to bring together technology, knowledge, multi-disciplinary expertise and science to help crack the problem of creating novel medicines for some of our worst diseases”.